In 2013, the MD Anderson Cancer Center launched a “moon shot” venture: diagnose and suggest therapy options for specific varieties of most cancers employing IBM’s Watson cognitive process. But in 2017, the challenge was put on keep after fees topped $sixty two million—and the method had nevertheless for use on patients. At the same time, t